David L. Ennist, PhD
Chief Science Officer
Dave is a biomedical scientist and business leader with broad experience in the biotech and pharma industry. He has published over 25 scientific articles in journals including Blood, PNAS, Journal of Immunology and Clinical Cancer Research. Dave’s expertise encompasses drug development, molecular biology, immunology, oncology, gene therapy, data analytics and research management.
Dave is formerly a Scientific Expert and Program Team Head for Novartis and Genetic Therapy, Inc., and Principal at DLE Consulting, where he consulted on drug development products from preclinical through phase 4 stages.
Dave holds a Bachelor’s degree from the University of Rochester, an MBA from the Johns Hopkins Carey Business School and a Doctorate from Ohio State University. He was a Staff Fellow and National Academy of Sciences Research Associate at the National Institutes of Health.